Pradžia › Pjautinio ląstelės anemija › Florida
Pjautinio ląstelės anemija klinikiniai tyrimai Florida
9 tyrimai dėl Pjautinio ląstelės anemija ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
Renkami dalyviai3 fazė
Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
Renkami dalyviai2/3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- ir dar 4
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
Renkami dalyviai2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
Renkami dalyviai3 fazė
Amžius nuo 10 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
Renkami dalyviai2 fazė
6 Months – 21 Years · Visoms lytims · Atnaujinta 2026-07-27 · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 14 iki 37 · Visoms lytims · Atnaujinta 2026-01-28 · NCT07373639Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.